1832 Asset Management L.P. Argenx Se Transaction History
1832 Asset Management L.P.
- $54.3 Billion
- Q3 2025
A detailed history of 1832 Asset Management L.P. transactions in Argenx Se stock. As of the latest transaction made, 1832 Asset Management L.P. holds 110,700 shares of ARGX stock, worth $101 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
110,700
Previous 172,400
35.79%
Holding current value
$101 Million
Previous $95 Million
14.08%
% of portfolio
0.15%
Previous 0.18%
Shares
9 transactions
Others Institutions Holding ARGX
# of Institutions
526Shares Held
26MCall Options Held
590KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...